2050816-56-1
2050816-56-1 structure
- Name: Ravagalimab
- Chemical Name: Ravagalimab
- CAS Number: 2050816-56-1
- Molecular Formula:
- Molecular Weight:
- Catalog: Research Areas Inflammation/Immunology
- Create Date: 2023-02-24 12:39:49
- Modify Date: 2024-04-11 13:18:20
-
Ravagalimab (ABBV-323) is a CD40 antagonist (EC50: 3.7 nM). Ravagalimab can be used for research of Crohn's disease[1].
| Name | Ravagalimab |
|---|
| Description | Ravagalimab (ABBV-323) is a CD40 antagonist (EC50: 3.7 nM). Ravagalimab can be used for research of Crohn's disease[1]. |
|---|---|
| Related Catalog | |
| Target |
CD40:3.7 nM (EC50) |
| In Vitro | Ravagalimab (0-100 nM，2 天) 抑制原代人 B 细胞上的 CD86 上调，EC50 为 0.6 nM[2]。 |
| References |
| No Any Chemical & Physical Properties |